Showing 1 - 20 results of 32 for search 'Katia Varani', query time: 0.06s Refine Results
  1. 1
    Design, synthesis and preliminary pharmacological evaluation of rigid analogues of the nicotinic agonist 1,1-dimethyl-4-phenylpiperazinium iodide (DMPP)

    Design, synthesis and preliminary pharmacological evaluation of rigid analogues of the nicotinic agonist 1,1-dimethyl-4-phenylpiperazinium iodide (DMPP) by Luca Guandalini, Elisabetta Martini, Fulvio Gualtieri, M. Novella Romanelli, Katia Varani

    Published 2004-04-01
    Get full text
    Article
  2. 2
    Design, synthesis and binding affinity of new nicotinic ligands

    Design, synthesis and binding affinity of new nicotinic ligands by Luca Guandalini, Elisabetta Martini, Paola Gratteri, Carla Ghelardini, Katia Varani, Maria Novella Romanelli

    Published 2006-05-01
    Get full text
    Article
  3. 3
    Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications

    Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications by Silvia Pasquini, Chiara Contri, Martina Cappello, Pier Andrea Borea, Katia Varani, Fabrizio Vincenzi

    Published 2022-10-01
    Get full text
    Article
  4. 4
    Piperazine- and Piperidine-Containing Thiazolo[5,4-<i>d</i>]pyrimidine Derivatives as New Potent and Selective Adenosine A<sub>2A</sub> Receptor Inverse Agonists

    Piperazine- and Piperidine-Containing Thiazolo[5,4-<i>d</i>]pyrimidine Derivatives as New Potent and Selective Adenosine A<sub>2A</sub> Receptor Inverse Agonists by Flavia Varano, Daniela Catarzi, Erica Vigiani, Fabrizio Vincenzi, Silvia Pasquini, Katia Varani, Vittoria Colotta

    Published 2020-07-01
    Get full text
    Article
  5. 5
    Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice

    Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice by Chiara Domenicale, Daniela Mercatelli, Federica Albanese, Salvatore Novello, Fabrizio Vincenzi, Katia Varani, Michele Morari

    Published 2022-04-01
    Get full text
    Article
  6. 6
    A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma

    A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma by Fabrizio Vincenzi, John Charles Rotondo, Silvia Pasquini, Francesco Di Virgilio, Katia Varani, Mauro Tognon

    Published 2021-10-01
    Get full text
    Article
  7. 7
    The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A<sub>1</sub>AR Positive Allosteric Modulation

    The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A<sub>1</sub>AR Positive Allosteric Modula... by Fabrizio Vincenzi, Silvia Pasquini, Stefania Gessi, Stefania Merighi, Romeo Romagnoli, Pier Andrea Borea, Katia Varani

    Published 2020-05-01
    Get full text
    Article
  8. 8
    A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic?

    A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic? by Fabrizio Vincenzi, Silvia Pasquini, Enrica Battistello, Stefania Merighi, Stefania Gessi, Pier Andrea Borea, Katia Varani

    Published 2020-12-01
    Get full text
    Article
  9. 9
    Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition

    Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition by Alessandro Papa, Silvia Pasquini, Chiara Contri, Sandra Gemma, Giuseppe Campiani, Stefania Butini, Katia Varani, Fabrizio Vincenzi

    Published 2022-01-01
    Get full text
    Article
  10. 10
    Adenosinergic System Involvement in Ischemic Stroke Patients’ Lymphocytes

    Adenosinergic System Involvement in Ischemic Stroke Patients’ Lymphocytes by Silvia Pasquini, Fabrizio Vincenzi, Ilaria Casetta, Michele Laudisi, Stefania Merighi, Stefania Gessi, Pier Andrea Borea, Katia Varani

    Published 2020-04-01
    Get full text
    Article
  11. 11
    Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease

    Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington disease by Alessia Tarditi, Alessandra Camurri, Katia Varani, Pier Andrea Borea, Ben Woodman, Gillian Bates, Elena Cattaneo, Maria P. Abbracchio

    Published 2006-07-01
    Get full text
    Article
  12. 12
    COMBINED TARGETING OF FATTY ACID AMIDE HYDROLASE AND MELATONIN RECEPTORS PROMOTES NEUROPROTECTION AND STIMULATES INFLAMMATION RESOLUTION IN RATS

    COMBINED TARGETING OF FATTY ACID AMIDE HYDROLASE AND MELATONIN RECEPTORS PROMOTES NEUROPROTECTION AND STIMULATES INFLAMMATION RESOLUTION IN RATS by Mariarosaria Cammarota, Francesca Ferlenghi, Federica Vacondio, Fabrizio Vincenzi, Katia Varani, Annalida Bedini, Silvia Rivara, Marco Mor, Francesca Boscia

    Published 2023-10-01
    Get full text
    Article
  13. 13
    An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?

    An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment? by Stefania Merighi, Tino Emanuele Poloni, Lucia Pelloni, Silvia Pasquini, Katia Varani, Fabrizio Vincenzi, Pier Andrea Borea, Stefania Gessi

    Published 2021-03-01
    Get full text
    Article
  14. 14
    A<sub>2A</sub> Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer’s Disease

    A<sub>2A</sub> Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer’s Disease by Stefania Gessi, Tino Emanuele Poloni, Giulia Negro, Katia Varani, Silvia Pasquini, Fabrizio Vincenzi, Pier Andrea Borea, Stefania Merighi

    Published 2021-09-01
    Get full text
    Article
  15. 15
    Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy

    Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy by Mercedes Fernandez, Manuela Nigro, Alessia Travagli, Silvia Pasquini, Fabrizio Vincenzi, Katia Varani, Pier Andrea Borea, Stefania Merighi, Stefania Gessi

    Published 2023-10-01
    Get full text
    Article
  16. 16
    A2B and A3 Adenosine Receptors Modulate Vascular Endothelial Growth Factor and Interleukin-8 Expression in Human Melanoma Cells Treated with Etoposide and Doxorubicin

    A2B and A3 Adenosine Receptors Modulate Vascular Endothelial Growth Factor and Interleukin-8 Expression in Human Melanoma Cells Treated with Etoposide and Doxorubicin by Stefania Merighi, Carolina Simioni, Stefania Gessi, Katia Varani, Prisco Mirandola, Mojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Pier Andrea Borea

    Published 2009-10-01
    Get full text
    Article
  17. 17
    Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease

    Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease by Antonella Ferrante, Alberto Martire, Rita Pepponi, Katia Varani, Fabrizio Vincenzi, Luca Ferraro, Sarah Beggiato, Maria Teresa Tebano, Patrizia Popoli

    Published 2014-11-01
    Get full text
    Article
  18. 18
    The anti-tumor effect of A3 adenosine receptors is potentiated by pulsed electromagnetic fields in cultured neural cancer cells.

    The anti-tumor effect of A3 adenosine receptors is potentiated by pulsed electromagnetic fields in cultured neural cancer cells. by Fabrizio Vincenzi, Martina Targa, Carmen Corciulo, Stefania Gessi, Stefania Merighi, Stefania Setti, Ruggero Cadossi, Pier Andrea Borea, Katia Varani

    Published 2012-01-01
    Get full text
    Article
  19. 19
    A2A adenosine receptors are involved in the reparative response of tendon cells to pulsed electromagnetic fields.

    A2A adenosine receptors are involved in the reparative response of tendon cells to pulsed electromagnetic fields. by Alessandra Colombini, Carlotta Perucca Orfei, Fabrizio Vincenzi, Paola De Luca, Enrico Ragni, Marco Viganò, Stefania Setti, Katia Varani, Laura de Girolamo

    Published 2020-01-01
    Get full text
    Article
  20. 20
    Pharmacology of Adenosine Receptors: Recent Advancements

    Pharmacology of Adenosine Receptors: Recent Advancements by Fabrizio Vincenzi, Silvia Pasquini, Chiara Contri, Martina Cappello, Manuela Nigro, Alessia Travagli, Stefania Merighi, Stefania Gessi, Pier Andrea Borea, Katia Varani

    Published 2023-09-01
    Get full text
    Article

Search Tools: